Related references
Note: Only part of the references are listed.MicroRNA expression signatures for the prediction of BRCA1/2 mutation-associated hereditary breast cancer in paraffin-embedded formalin-fixed breast tumors
Miljana Tanic et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
The TGFβ-miR200-MIG6 Pathway Orchestrates the EMT-Associated Kinase Switch That Induces Resistance to EGFR Inhibitors
Evgeny Izumchenko et al.
CANCER RESEARCH (2014)
HER2 aberrations in cancer: Implications for therapy
Min Yan et al.
CANCER TREATMENT REVIEWS (2014)
MicroRNAs in personalized cancer therapy
S. Sethi et al.
CLINICAL GENETICS (2014)
A microRNA meta-signature for pancreatic ductal adenocarcinoma
Adam E. Frampton et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2014)
MicroRNAs Cooperatively Inhibit a Network of Tumor Suppressor Genes to Promote Pancreatic Tumor Growth and Progression
Adam E. Frampton et al.
GASTROENTEROLOGY (2014)
miRNAs for the Detection of MultiDrug Resistance: Overview and Perspectives
Andreas Gisel et al.
MOLECULES (2014)
Macrophages mediate gemcitabine resistance of pancreatic adenocarcinoma by upregulating cytidine deaminase
N. Weizman et al.
ONCOGENE (2014)
Differentially Expressed miRNAs in Cancer-Stem-Like Cells: Markers for Tumor Cell Aggressiveness of Pancreatic Cancer
Bin Bao et al.
STEM CELLS AND DEVELOPMENT (2014)
MiR-148a regulates the growth and apoptosis in pancreatic cancer by targeting CCKBR and Bcl-2
Rui Zhang et al.
TUMOR BIOLOGY (2014)
Role of pancreatic stellate cells in chemoresistance in pancreatic cancer
Joshua A. McCarroll et al.
FRONTIERS IN PHYSIOLOGY (2014)
The good, the bad and the ugly: a tale of miR-101, miR-21 and miR-155 in pancreatic intraductal papillary mucinous neoplasms
S. Caponi et al.
ANNALS OF ONCOLOGY (2013)
Multicenter phase II trial to investigate safety and efficacy of gemcitabine combined with cetuximab as adjuvant therapy in pancreatic cancer (ATIP)
H. Fensterer et al.
ANNALS OF ONCOLOGY (2013)
miR-210 regulates the interaction between pancreatic cancer cells and stellate cells
Tetsuya Takikawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Stromal disrupting effects of nab-paclitaxel in pancreatic cancer
R. Alvarez et al.
BRITISH JOURNAL OF CANCER (2013)
Clinical impact of circulating miR-221 in plasma of patients with pancreatic cancer
T. Kawaguchi et al.
BRITISH JOURNAL OF CANCER (2013)
miR-320c regulates gemcitabine-resistance in pancreatic cancer via SMARCC1
Y. Iwagami et al.
BRITISH JOURNAL OF CANCER (2013)
Aberrant MicroRNAs Expression Patterns in Pancreatic Cancer and Their Clinical Translation
Yiqi Du et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2013)
Targeting microRNAs in Pancreatic Cancer: Microplayers in the Big Game
Sheema Khan et al.
CANCER RESEARCH (2013)
miRNA in clinical practice: Pancreatic cancer
Marine Humeau et al.
CLINICAL BIOCHEMISTRY (2013)
miRNAs in Insulin Resistance and Diabetes-Associated Pancreatic Cancer: The 'Minute and Miracle' Molecule Moving as a Monitor in the 'Genomic Galaxy'
Chiranjib Chakraborty et al.
CURRENT DRUG TARGETS (2013)
MicroRNAs as therapeutic targets in chemoresistance
Michela Garofalo et al.
DRUG RESISTANCE UPDATES (2013)
The HER2-miR125a5p/miR125b loop in gastric and esophageal carcinogenesis
Matteo Fassan et al.
HUMAN PATHOLOGY (2013)
An Undesired Effect of Chemotherapy GEMCITABINE PROMOTES PANCREATIC CANCER CELL INVASIVENESS THROUGH REACTIVE OXYGEN SPECIES-DEPENDENT, NUCLEAR FACTOR κB- AND HYPOXIA-INDUCIBLE FACTOR 1α-MEDIATED UP-REGULATION OF CXCR4
Sumit Arora et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Candidate microRNA biomarkers of pancreatic ductal adenocarcinoma: meta-analysis, experimental validation and clinical significance
Ming-Zhe Ma et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2013)
Hypoxia induces the overexpression of microRNA-21 in pancreatic cancer cells
Thomas A. Mace et al.
JOURNAL OF SURGICAL RESEARCH (2013)
MicroRNAs and other non-coding RNAs as targets for anticancer drug development
Hui Ling et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Long non-coding RNA identification over mouse brain development by integrative modeling of chromatin and genomic features
Jie Lv et al.
NUCLEIC ACIDS RESEARCH (2013)
Sweating the Small Stuff MicroRNAs and Genetic Changes Define Pancreatic Cancer
Siuwah Tang et al.
PANCREAS (2013)
Toward a Better Understanding of Pancreatic Ductal Adenocarcinoma Glimmers of Hope?
Christian Partensky
PANCREAS (2013)
Expression of MicroRNAs in Patients With Pancreatic Cancer and Its Prognostic Significance
Ioannis G. Papaconstantinou et al.
PANCREAS (2013)
Differential Processing of let-7a Precursors Influences RRM2 Expression and Chemosensitivity in Pancreatic Cancer: Role of LIN-28 and SET Oncoprotein
Yangzom Doma Bhutia et al.
PLOS ONE (2013)
MicroRNA-mediated control of macrophages and its implications for cancer
Mario Leonardo Squadrito et al.
TRENDS IN IMMUNOLOGY (2013)
Clinical and molecular characterization of HER2 amplified-pancreatic cancer
Angela Chou et al.
GENOME MEDICINE (2013)
MicroRNAs in Kidney Fibrosis and Diabetic Nephropathy: Roles on EMT and EndMT
Swayam Prakash Srivastava et al.
BIOMED RESEARCH INTERNATIONAL (2013)
MicroRNA-gene signaling pathways in pancreatic cancer
Dimitrios Iliopoulos et al.
Biomedical Journal (2013)
Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up
T. Seufferlein et al.
ANNALS OF ONCOLOGY (2012)
Neoadjuvant/Preoperative Gemcitabine for Patients with Localized Pancreatic Cancer: A Meta-analysis of Prospective Studies
Angelo Andriulli et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
MicroRNA-10a is Overexpressed in Human Pancreatic Cancer and Involved in Its Invasiveness Partially via Suppression of the HOXA1 Gene
Kenoki Ohuchida et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
MicroRNA-214 Regulates the Acquired Resistance to Gefitinib via the PTEN/AKT Pathway in EGFR-mutant Cell Lines
Yong-Sheng Wang et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
A microRNA gene expression signature predicts response to erlotinib in epithelial cancer cell lines and targets EMT
J. L. Bryant et al.
BRITISH JOURNAL OF CANCER (2012)
Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer
J. Harder et al.
BRITISH JOURNAL OF CANCER (2012)
MicroRNAs in Stress Signaling and Human Disease
Joshua T. Mendell et al.
CELL (2012)
MicroRNA Molecular Profiles Associated with Diagnosis, Clinicopathologic Criteria, and Overall Survival in Patients with Resectable Pancreatic Ductal Adenocarcinoma
Nigel B. Jamieson et al.
CLINICAL CANCER RESEARCH (2012)
The Pancreas Cancer Microenvironment
Christine Feig et al.
CLINICAL CANCER RESEARCH (2012)
Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice
Elisa Giovannetti et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2012)
Advances in Biomarker Research for Pancreatic Cancer
Kruttika Bhat et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
miR-17-5p Inhibitor Enhances Chemosensitivity to Gemcitabine Via Upregulating Bim Expression in Pancreatic Cancer Cells
Hai-jiao Yan et al.
DIGESTIVE DISEASES AND SCIENCES (2012)
Treatment options for advanced pancreatic cancer: a review
Rahma Warsame et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2012)
Occupational risk factors and pancreatic cancer: A review of recent findings
Gabriella Andreotti et al.
MOLECULAR CARCINOGENESIS (2012)
Landscape of transcription in human cells
Sarah Djebali et al.
NATURE (2012)
An integrated encyclopedia of DNA elements in the human genome
Ian Dunham et al.
NATURE (2012)
New biomarkers and targets in pancreatic cancer and their application to treatment
Eithne Costello et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2012)
Long non-coding RNAs and cancer: a new frontier of translational research?
R. Spizzo et al.
ONCOGENE (2012)
MicroRNAs Targeting Oncogenes Are Down-Regulated in Pancreatic Malignant Transformation from Benign Tumors
Long R. Jiao et al.
PLOS ONE (2012)
Hypoxia-Induced Aggressiveness of Pancreatic Cancer Cells Is Due to Increased Expression of VEGF, IL-6 and miR-21, Which Can Be Attenuated by CDF Treatment
Bin Bao et al.
PLOS ONE (2012)
High-Throughput MicroRNA (miRNAs) Arrays Unravel the Prognostic Role of MiR-211 in Pancreatic Cancer
Elisa Giovannetti et al.
PLOS ONE (2012)
Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors
Triantafyllos Stylianopoulos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
nab-Paclitaxel Potentiates Gemcitabine Activity by Reducing Cytidine Deaminase Levels in a Mouse Model of Pancreatic Cancer
Kristopher K. Frese et al.
CANCER DISCOVERY (2012)
The role of inflammatory cells in fostering pancreatic cancer cell growth and invasion
Anthony Evans et al.
FRONTIERS IN PHYSIOLOGY (2012)
MicroRNA Expression as a Predictive Marker for Gemcitabine Response after Surgical Resection of Pancreatic Cancer
Kenoki Ohuchida et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Bcl-2 Upregulation Induced by miR-21 Via a Direct Interaction Is Associated with Apoptosis and Chemoresistance in MIA PaCa-2 Pancreatic Cancer Cells
Jie Dong et al.
ARCHIVES OF MEDICAL RESEARCH (2011)
MicroRNA 421 suppresses DPC4/Smad4 in pancreatic cancer
Jun Hao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
MicroRNA-10b Expression Correlates with Response to Neoadjuvant Therapy and Survival in Pancreatic Ductal Adenocarcinoma
Meir Preis et al.
CLINICAL CANCER RESEARCH (2011)
microRNA-10b: A New Marker or the Marker of Pancreatic Ductal Adenocarcinoma?
Tetsuro Setoyama et al.
CLINICAL CANCER RESEARCH (2011)
MicroRNA 483-3p suppresses the expression of DPC4/Smad4 in pancreatic cancer
Jun Hao et al.
FEBS LETTERS (2011)
Stromal biology and therapy in pancreatic cancer
Albrecht Neesse et al.
GUT (2011)
Non-coding RNAs in human disease
Manel Esteller
NATURE REVIEWS GENETICS (2011)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Molecular Pathogenesis of Pancreatic Cancer and Clinical Perspectives
D. Matthaios et al.
ONCOLOGY (2011)
Human SMG-1 is Involved in Gemcitabine-Induced Primary microRNA-155/BIC Up-Regulation in Human Pancreatic Cancer PANC-1 Cells
Qi-sheng Xia et al.
PANCREAS (2011)
Elevated microRNA miR-21 Levels in Pancreatic Cyst Fluid Are Predictive of Mucinous Precursor Lesions of Ductal Adenocarcinoma
Ji Kon Ryu et al.
PANCREATOLOGY (2011)
Targeting Epigenetic Regulation of miR-34a for Treatment of Pancreatic Cancer by Inhibition of Pancreatic Cancer Stem Cells
Dara Nalls et al.
PLOS ONE (2011)
Role of primary miRNA polymorphic variants in metastatic colon cancer patients treated with 5-fluorouracil and irinotecan
V. Boni et al.
PHARMACOGENOMICS JOURNAL (2011)
Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas
Markus Vogt et al.
VIRCHOWS ARCHIV (2011)
MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis and involved in cancer cell proliferation and invasion
Jun Yu et al.
CANCER BIOLOGY & THERAPY (2010)
miRNA-96 Suppresses KRAS and Functions as a Tumor Suppressor Gene in Pancreatic Cancer
Shuangni Yu et al.
CANCER RESEARCH (2010)
MicroRNA-21 in Pancreatic Cancer: Correlation with Clinical Outcome and Pharmacologic Aspects Underlying Its Role in the Modulation of Gemcitabine Activity
Elisa Giovannetti et al.
CANCER RESEARCH (2010)
EGFR Promotes Lung Tumorigenesis by Activating miR-7 through a Ras/ERK/Myc Pathway That Targets the Ets2 Transcriptional Repressor ERF
Yu-Ting Chou et al.
CANCER RESEARCH (2010)
被撤回的出版物: Gemcitabine Sensitivity Can Be Induced in Pancreatic Cancer Cells through Modulation of miR-200 and miR-21 Expression by Curcumin or Its Analogue CDF (Retracted article. See vol. 78, pg. 5466, 2018)
Shadan Ali et al.
CANCER RESEARCH (2010)
Non-codingRNA sequence variations in human chronic lymphocytic leukemia and colorectal cancer
Sylwia E. Wojcik et al.
CARCINOGENESIS (2010)
The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS
Wu-Gan Zhao et al.
CARCINOGENESIS (2010)
MicroRNA-21 Is Induced Early in Pancreatic Ductal Adenocarcinoma Precursor Lesions
Mael Chalret du Rieu et al.
CLINICAL CHEMISTRY (2010)
PALB2 mutations in European familial pancreatic cancer families
E. P. Slater et al.
CLINICAL GENETICS (2010)
Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival
Thomas Greither et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection A Randomized Controlled Trial
John P. Neoptolemos et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Single-Agent Gemcitabine As First-Line Treatment of Patients With Advanced Pancreatic Cancer: The GIP-1 Study
Giuseppe Colucci et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Dysregulation of miR-15a and miR-214 in human pancreatic cancer
Xing J. Zhang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2010)
MicroRNA, hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell proliferation
Jun Yu et al.
MOLECULAR CANCER (2010)
miR-192/miR-215 Influence 5-Fluorouracil Resistance through Cell Cycle-Mediated Mechanisms Complementary to Its Post-transcriptional Thymidilate Synthase Regulation
Valentina Boni et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model
Li Ma et al.
NATURE BIOTECHNOLOGY (2010)
Advanced pancreatic carcinoma: current treatment and future challenges
Anastasios Stathis et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Identification of MicroRNA-21 as a Biomarker for Chemoresistance and Clinical Outcome Following Adjuvant Therapy in Resectable Pancreatic Cancer
Jin-Hyeok Hwang et al.
PLOS ONE (2010)
MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2)
Nicola Valeri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer
Allen S. Ho et al.
TRANSLATIONAL ONCOLOGY (2010)
Up-regulation of miR-200 and let-7 by Natural Agents Leads to the Reversal of Epithelial-to-Mesenchymal Transition in Gemcitabine-Resistant Pancreatic Cancer Cells
Yiwei Li et al.
CANCER RESEARCH (2009)
HER2 overexpression correlates with survival after curative resection of pancreatic cancer
Masahiro Komoto et al.
CANCER SCIENCE (2009)
MicroRNAs and genomic variations: from Proteus tricks to Prometheus gift
Muller Fabbri et al.
CARCINOGENESIS (2009)
MiR-21 Indicates Poor Prognosis in Tongue Squamous Cell Carcinomas as an Apoptosis Inhibitor
Jinsong Li et al.
CLINICAL CANCER RESEARCH (2009)
SMAD4 Gene Mutations Are Associated with Poor Prognosis in Pancreatic Cancer
Amanda Blackford et al.
CLINICAL CANCER RESEARCH (2009)
Regulation of Epidermal Growth Factor Receptor Signaling in Human Cancer Cells by MicroRNA-7
Rebecca J. Webster et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer
David Cunningham et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
DPC4 Gene Status of the Primary Carcinoma Correlates With Patterns of Failure in Patients With Pancreatic Cancer
Christine A. Iacobuzio-Donahue et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Small RNA: A Large Contributor to Carcinogenesis?
Imran Bhatti et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2009)
The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma
Lei Chen et al.
JOURNAL OF HEPATOLOGY (2009)
MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents
Dawn R. Cochrane et al.
MOLECULAR CANCER THERAPEUTICS (2009)
MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance
Taiki Moriyama et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Next generation oncology drug development: opportunities and challenges
Martin E. Gutierrez et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
Causes and consequences of microRNA dysregulation in cancer
Carlo M. Croce
NATURE REVIEWS GENETICS (2009)
Antisense Inhibition of microRNA-21 or-221 Arrests Cell Cycle, Induces Apoptosis, and Sensitizes the Effects of Gemcitabine in Pancreatic Adenocarcinoma
Jong-Kook Park et al.
PANCREAS (2009)
MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating Cells
Qing Ji et al.
PLOS ONE (2009)
Regulation of HIF-1α and VEGF by miR-20b Tunes Tumor Cells to Adapt to the Alteration of Oxygen Concentration
Zhang Lei et al.
PLOS ONE (2009)
Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene
Sian Jones et al.
SCIENCE (2009)
MicroRNAs: Control and Loss of Control in Human Physiology and Disease
Min Li et al.
WORLD JOURNAL OF SURGERY (2009)
Quantitative differential expression analysis reveals miR-7 as major islet microRNA
Valia Bravo-Egana et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells
Hua Zhu et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Meta-analysis of randomized trials: Evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer
Volker Heinemann et al.
BMC CANCER (2008)
Coordinated epidermal growth factor receptor pathway gene overexpression predicts epidermal growth factor receptor inhibitor sensitivity in pancreatic cancer
Antonio Jimeno et al.
CANCER RESEARCH (2008)
Pancreatic cancer-associated diabetes mellitus: Prevalence and temporal association with diagnosis of cancer
Suresh T. Chari et al.
GASTROENTEROLOGY (2008)
MicroRNA-10a binds the 5′UTR of ribosomal protein mRNAs and enhances their translation
Ulf Andersson Orom et al.
MOLECULAR CELL (2008)
MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation
Yvonne Tay et al.
NATURE (2008)
Circulating microRNAs as stable blood-based markers for cancer detection
Patrick S. Mitchell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses
Sian Jones et al.
SCIENCE (2008)
Switching from repression to activation: MicroRNAs can up-regulate translation
Shobha Vasudevan et al.
SCIENCE (2007)
Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development
Meritxell Gironella et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B
Muller Fabbri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Regulation of the p27Kip1 tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation
Carlos le Sage et al.
EMBO JOURNAL (2007)
p53-mediated activation of miRNA34 candidate tumor-suppressor genes
Guido T. Bommer et al.
CURRENT BIOLOGY (2007)
Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer
Asma Sultana et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5′ UTR as in the 3′ UTR
J. Robin Lytle et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada clinical trials group
Malcolm J. Moore et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
A microRNA signature of hypoxia
Ritu Kulshreshtha et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer - A Randomized controlled trial
Helmut Oettle et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
MicroRNA signatures in human cancers
George A. Calin et al.
NATURE REVIEWS CANCER (2006)
Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2
Bing Xia et al.
MOLECULAR CELL (2006)
Molecular biomarkers: their increasing role in the diagnosis, characterization, and therapy guidance in pancreatic cancer
A Jimeno et al.
MOLECULAR CANCER THERAPEUTICS (2006)
A microRNA expression signature of human solid tumors defines cancer gene targets
S Volinia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
IntronicMicroRNA (miRNA)
Shi-Lung Lin et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2006)
microPrimer: The biogenesis and function of microRNA
TT Du et al.
DEVELOPMENT (2005)
Homozygous deletion of the MTAP gene in invasive adenocarcinoma of the pancreas and in periampullary cancer
SR Hustinx et al.
CANCER BIOLOGY & THERAPY (2005)
Hypoxia increases resistance of human pancreatic cancer cells to apoptosis induced by gemcitabine
K Yokoi et al.
CLINICAL CANCER RESEARCH (2004)
A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer
JP Neoptolemos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
GA Calin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Micrornas: Small RNAs with a big role in gene regulation
L He et al.
NATURE REVIEWS GENETICS (2004)
Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs
XZ Cai et al.
RNA (2004)
Processing of primary microRNAs by the Microprocessor complex
AM Denli et al.
NATURE (2004)
The Microprocessor complex mediates the genesis of microRNAs
RI Gregory et al.
NATURE (2004)
MicroRNA genes are transcribed by RNA polymerase II
Y Lee et al.
EMBO JOURNAL (2004)
Smad-dependent and Smad-independent pathways in TGF-β family signalling
R Derynck et al.
NATURE (2003)
The nuclear RNase III Drosha initiates microRNA processing
Y Lee et al.
NATURE (2003)
Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer
CM Ribic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
MicroRNA pathways in flies and worms: Growth, death, fat, stress, and timing
V Ambros
CELL (2003)
The biology of VEGF and its receptors
N Ferrara et al.
NATURE MEDICINE (2003)
Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
GA Calin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Multidrug resistance in cancer: Role of ATP-dependent transporters
MM Gottesman et al.
NATURE REVIEWS CANCER (2002)
Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C-elegans
RF Ketting et al.
GENES & DEVELOPMENT (2001)
A role for the RNase III enzyme DCR-1 in RNA interference and germ line development in Caenorhabditis elegans
SW Knight et al.
SCIENCE (2001)
Pancreatic tumors show high levels of hypoxia
AC Koong et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2000)
Abnormal glucose metabolism and pancreatic cancer mortality
SM Gapstur et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Induction of apoptosis by cancer chemotherapy
SH Kaufmann et al.
EXPERIMENTAL CELL RESEARCH (2000)
The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans
BJ Reinhart et al.
NATURE (2000)
Share Paper
